Strategic leadership Optos has recently appointed a new CEO in June 2026, signaling potential strategic shifts, new initiatives, and renewed focus on growth. This is an opportune moment to engage with executive leadership to discuss roadmap alignment, product enhancements, and partnerships.

Product expansion The company is expanding capabilities with features like AreaAssist through OptosAdvance and the Silverstone RGB release, as well as integration of image-guided OCT. These advancements present opportunities to upsell advanced imaging workflows, clinical decision support, and value-added hardware bundles.

Clinical footprint Optos devices are already deployed in high-visibility healthcare settings including Great Ormond Street Hospital and Harvard Medical Center. This established clinical presence enables case-study driven selling, referenceable sites, and targeted outreach to leading ophthalmology networks and hospitals.

Partnership potential Recent partnerships and integrations, such as with Toku’s BioAge solution, indicate openness to ecosystem collaborations. This creates openings for co-marketing, data interoperability projects, and bundled offerings with compatible diagnostic tools and analytics platforms.

Market position As a Nikon division with a strong install base and 82% retinal imaging capability, Optos targets ophthalmology clinics and optometry practices with an emphasis on ultra-widefield imaging. The opportunity lies in competing on comprehensive retina care workflows, including diabetic retinopathy and AMD management, to win larger practice-wide purchases.